|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000157992 |
Summary for KRTCAP3 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000157992 | Gene symbol | KRTCAP3 |
| Gene name | keratinocyte associated protein 3 | |
| HGNC | 28943 | |
| Entrez ID | 200634 | |
| Gene type | protein_coding | |
| Synonyms | KRTCAP3|KCP3 | |
| UniProtAcc | Q53RY4 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for KRTCAP3 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KRTCAP3 | 1.73e+03 | 1.17e+00 | 4.91e-01 | 2.39e+00 | 1.67e-02 | 3.69e-02 | BLCA |
| KRTCAP3 | 1.57e+03 | 2.50e+00 | 4.27e-01 | 5.86e+00 | 4.64e-09 | 5.66e-08 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for KRTCAP3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for KRTCAP3 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg26034919 | chr2:27442844 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 3.58e-01 | 2.50e-01 | 2.30e+00 | 2.14e-02 | 3.59e-02 | 1.08e-01 |
| HNSC | cg12000995 | chr2:27442272 | CGI:chr2:27442072-27442803 | promoter | 4.47e-01 | 3.06e-01 | 6.00e+00 | 1.99e-09 | 2.61e-08 | 1.40e-01 |
| HNSC | cg12648201 | chr2:27442274 | CGI:chr2:27442072-27442803 | promoter | 4.74e-01 | 3.50e-01 | 5.99e+00 | 2.08e-09 | 2.73e-08 | 1.24e-01 |
| HNSC | cg21248554 | chr2:27442283 | CGI:chr2:27442072-27442803 | promoter | 5.13e-01 | 3.99e-01 | 6.65e+00 | 2.96e-11 | 4.12e-10 | 1.14e-01 |
| HNSC | cg20102877 | chr2:27442771 | CGI:chr2:27442072-27442803 | promoter,exon,gene body | 6.49e-01 | 5.32e-01 | 6.45e+00 | 1.14e-10 | 1.55e-09 | 1.17e-01 |
| HNSC | cg24768116 | chr2:27442261 | CGI:chr2:27442072-27442803 | promoter | 5.25e-01 | 4.23e-01 | 6.25e+00 | 4.15e-10 | 5.59e-09 | 1.02e-01 |
| HNSC | cg26034919 | chr2:27442844 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 5.16e-01 | 3.94e-01 | 6.22e+00 | 4.92e-10 | 6.59e-09 | 1.22e-01 |
| LIHC | cg12648201 | chr2:27442274 | CGI:chr2:27442072-27442803 | promoter | 5.91e-01 | 6.97e-01 | -2.52e+00 | 1.18e-02 | 1.97e-02 | -1.06e-01 |
| ACC | cg02592271 | chr2:27442640 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 6.79e-01 | 8.23e-01 | -2.84e+00 | 4.49e-03 | 1.60e-02 | -1.43e-01 |
| ACC | cg12000995 | chr2:27442272 | CGI:chr2:27442072-27442803 | promoter | 5.30e-01 | 7.49e-01 | -2.44e+00 | 1.47e-02 | 3.10e-02 | -2.19e-01 |
| ACC | cg12648201 | chr2:27442274 | CGI:chr2:27442072-27442803 | promoter | 5.70e-01 | 7.87e-01 | -2.36e+00 | 1.83e-02 | 3.42e-02 | -2.17e-01 |
| ACC | cg21248554 | chr2:27442283 | CGI:chr2:27442072-27442803 | promoter | 5.78e-01 | 7.41e-01 | -2.16e+00 | 3.09e-02 | 4.19e-02 | -1.63e-01 |
| ACC | cg24768116 | chr2:27442261 | CGI:chr2:27442072-27442803 | promoter | 5.53e-01 | 7.13e-01 | -2.84e+00 | 4.49e-03 | 1.60e-02 | -1.60e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| THCA | cg18428193 | chr2:27442150 | CGI:chr2:27442072-27442803 | promoter | 7.33e-01 | 5.77e-01 | 4.20e+00 | 2.72e-05 | 2.43e-04 | 1.56e-01 |
| THCA | cg04845466 | chr2:27442212 | CGI:chr2:27442072-27442803 | promoter | 4.84e-01 | 3.81e-01 | 3.10e+00 | 1.93e-03 | 5.05e-03 | 1.03e-01 |
| COAD | cg18428193 | chr2:27442150 | CGI:chr2:27442072-27442803 | promoter | 5.41e-01 | 4.35e-01 | 2.71e+00 | 6.74e-03 | 1.05e-02 | 1.06e-01 |
| CHOL | cg18428193 | chr2:27442150 | CGI:chr2:27442072-27442803 | promoter | 6.56e-01 | 8.40e-01 | -1.99e+00 | 4.65e-02 | 4.65e-02 | -1.84e-01 |
| CHOL | cg20102877 | chr2:27442771 | CGI:chr2:27442072-27442803 | promoter,exon,gene body | 4.63e-01 | 5.91e-01 | -2.51e+00 | 1.22e-02 | 2.39e-02 | -1.27e-01 |
| CHOL | cg04845466 | chr2:27442212 | CGI:chr2:27442072-27442803 | promoter | 4.87e-01 | 6.17e-01 | -2.06e+00 | 3.90e-02 | 4.26e-02 | -1.30e-01 |
| CHOL | cg26034919 | chr2:27442844 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 3.33e-01 | 5.15e-01 | -2.73e+00 | 6.38e-03 | 1.82e-02 | -1.82e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg26034919 | chr2:27442844 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 3.58e-01 | 4.76e-01 | -8.03e+00 | 9.90e-16 | 3.81e-15 | -1.18e-01 |
| LUAD | cg12000995 | chr2:27442272 | CGI:chr2:27442072-27442803 | promoter | 2.84e-01 | 3.96e-01 | -2.28e+00 | 2.26e-02 | 2.82e-02 | -1.12e-01 |
| LUAD | cg04845466 | chr2:27442212 | CGI:chr2:27442072-27442803 | promoter | 4.79e-01 | 5.82e-01 | -3.23e+00 | 1.23e-03 | 3.66e-03 | -1.02e-01 |
| HNSC | cg18428193 | chr2:27442150 | CGI:chr2:27442072-27442803 | promoter | 7.30e-01 | 4.81e-01 | 3.13e+00 | 1.73e-03 | 9.52e-03 | 2.49e-01 |
| HNSC | cg12000995 | chr2:27442272 | CGI:chr2:27442072-27442803 | promoter | 4.47e-01 | 2.18e-01 | 2.30e+00 | 2.17e-02 | 2.89e-02 | 2.28e-01 |
| HNSC | cg12648201 | chr2:27442274 | CGI:chr2:27442072-27442803 | promoter | 4.74e-01 | 2.47e-01 | 2.51e+00 | 1.20e-02 | 2.06e-02 | 2.27e-01 |
| HNSC | cg21248554 | chr2:27442283 | CGI:chr2:27442072-27442803 | promoter | 5.13e-01 | 3.37e-01 | 2.40e+00 | 1.65e-02 | 2.46e-02 | 1.76e-01 |
| HNSC | cg17158414 | chr2:27442439 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 6.07e-01 | 4.88e-01 | 2.35e+00 | 1.86e-02 | 2.64e-02 | 1.19e-01 |
| HNSC | cg02592271 | chr2:27442640 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 5.63e-01 | 4.36e-01 | 2.45e+00 | 1.41e-02 | 2.25e-02 | 1.27e-01 |
| HNSC | cg20102877 | chr2:27442771 | CGI:chr2:27442072-27442803 | promoter,exon,gene body | 6.49e-01 | 4.19e-01 | 3.00e+00 | 2.72e-03 | 1.06e-02 | 2.30e-01 |
| HNSC | cg04845466 | chr2:27442212 | CGI:chr2:27442072-27442803 | promoter | 6.00e-01 | 4.09e-01 | 2.69e+00 | 7.10e-03 | 1.57e-02 | 1.91e-01 |
| HNSC | cg24768116 | chr2:27442261 | CGI:chr2:27442072-27442803 | promoter | 5.25e-01 | 3.70e-01 | 2.23e+00 | 2.59e-02 | 3.23e-02 | 1.55e-01 |
| HNSC | cg11618577 | chr2:27442676 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 5.16e-01 | 4.00e-01 | 2.47e+00 | 1.37e-02 | 2.21e-02 | 1.16e-01 |
| HNSC | cg26034919 | chr2:27442844 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 5.16e-01 | 2.64e-01 | 2.99e+00 | 2.83e-03 | 1.08e-02 | 2.51e-01 |
| BLCA | cg12000995 | chr2:27442272 | CGI:chr2:27442072-27442803 | promoter | 2.80e-01 | 3.97e-01 | -1.98e+00 | 4.81e-02 | 4.85e-02 | -1.17e-01 |
| BLCA | cg12648201 | chr2:27442274 | CGI:chr2:27442072-27442803 | promoter | 3.09e-01 | 4.26e-01 | -2.39e+00 | 1.70e-02 | 2.44e-02 | -1.17e-01 |
| BLCA | cg21248554 | chr2:27442283 | CGI:chr2:27442072-27442803 | promoter | 3.65e-01 | 5.06e-01 | -2.52e+00 | 1.19e-02 | 1.94e-02 | -1.41e-01 |
| BLCA | cg20102877 | chr2:27442771 | CGI:chr2:27442072-27442803 | promoter,exon,gene body | 4.73e-01 | 6.11e-01 | -2.72e+00 | 6.50e-03 | 1.33e-02 | -1.38e-01 |
| BLCA | cg04845466 | chr2:27442212 | CGI:chr2:27442072-27442803 | promoter | 4.77e-01 | 5.82e-01 | -2.10e+00 | 3.62e-02 | 4.01e-02 | -1.05e-01 |
| BLCA | cg26034919 | chr2:27442844 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 3.50e-01 | 4.96e-01 | -2.69e+00 | 7.17e-03 | 1.42e-02 | -1.46e-01 |
| KIRP | cg17158414 | chr2:27442439 | CGI:chr2:27442072-27442803 | promoter,exon,CDS,gene body | 6.82e-01 | 5.44e-01 | 2.04e+00 | 4.11e-02 | 4.37e-02 | 1.39e-01 |
Top |
Exon skipping events with PSI in TCGA for KRTCAP3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| COAD | exon_skip_324175 | 5.45e-01 | 6.59e-01 | -2.57e+00 | 1.00e-02 | 1.76e-02 | -1.14e-01 |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| READ | exon_skip_324175 | 5.76e-01 | 7.29e-01 | -2.08e+00 | 3.78e-02 | 4.34e-02 | -1.53e-01 |
Top |
RNA A-to-I editing events in TCGA for KRTCAP3 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for KRTCAP3 |
TFs related to KRTCAP3.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
KRTCAP3 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for KRTCAP3 |
RBPs related to ES in KRTCAP3.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
KRTCAP3 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs60689851 | chr2:29777341:A:G | - | 0.396086392382842 | 0.0372533684938786 | LIHC | Female-baised eQTL |
| rs72786257 | chr2:29770047:G:T | - | 0.395883211036069 | 0.0375029481008606 | LIHC | Female-baised eQTL |
| rs72786258 | chr2:29770207:G:T | - | 0.395883211036069 | 0.0375029481008606 | LIHC | Female-baised eQTL |
| rs72851987 | chr2:29770578:T:A | - | 0.395883211036069 | 0.0375029481008606 | LIHC | Female-baised eQTL |
| rs145213781 | chr2:29771600:T:C | - | 0.395883211036069 | 0.0375029481008606 | LIHC | Female-baised eQTL |
| rs9973437 | chr2:29776973:G:C | - | 0.395883211036069 | 0.0375029481008606 | LIHC | Female-baised eQTL |
| rs61742608 | chr2:18584857:C:T | - | 0.213545723300949 | 0.00518347984711099 | LUSC | Female-baised eQTL |
| rs16985315 | chr2:18606130:A:C | - | 0.21253871680012 | 0.00573848476960653 | LUSC | Female-baised eQTL |
| rs73916890 | chr2:18593837:G:A | - | 0.202789208566079 | 0.00976285508215614 | LUSC | Female-baised eQTL |
| rs7574859 | chr2:29871343:T:G | - | 0.144433724014128 | 0.0105335906645129 | LUSC | Female-baised eQTL |
| rs7597555 | chr2:29859664:G:A | - | 0.152050843608247 | 0.0107670642426884 | LUSC | Female-baised eQTL |
| rs11675197 | chr2:29878150:T:C | - | 0.143719461387574 | 0.0113626937739037 | LUSC | Female-baised eQTL |
| rs73916879 | chr2:18565624:A:C | - | 0.200488531988711 | 0.0117932109314405 | LUSC | Female-baised eQTL |
| rs7603601 | chr2:18574830:C:T | - | 0.200488531988711 | 0.0117932109314405 | LUSC | Female-baised eQTL |
| rs16985296 | chr2:18582704:A:G | - | 0.200488531988711 | 0.0117932109314405 | LUSC | Female-baised eQTL |
| rs57866978 | chr2:18570322:T:C | - | 0.205276073162615 | 0.0152015412139133 | LUSC | Female-baised eQTL |
| rs76872536 | chr2:29873806:C:T | - | 0.147951752131624 | 0.0189895231239686 | LUSC | Female-baised eQTL |
| rs72794343 | chr2:29892984:A:G | - | 0.156271116194894 | 0.0251923798107178 | LUSC | Female-baised eQTL |
| rs4233749 | chr2:29848229:G:A | - | -0.134304937583027 | 0.0279562460562777 | LUSC | Female-baised eQTL |
| rs7586014 | chr2:29867043:G:A | - | 0.145005669406977 | 0.0290263944506982 | LUSC | Female-baised eQTL |
| rs7592233 | chr2:18562851:A:G | - | 0.211366546329342 | 0.0317720208350045 | LUSC | Female-baised eQTL |
| rs71446030 | chr2:31928474:G:A | - | 0.229022664358476 | 0.0465179331527229 | LUSC | Female-baised eQTL |
| rs6547829 | chr2:28101002:C:T | - | 0.128575774953924 | 0.0197546884495531 | COAD | Female-baised eQTL |
| rs116765897 | chr2:28089906:G:A | - | 0.125603417183955 | 0.0264627308677426 | COAD | Female-baised eQTL |
| rs1275529 | chr2:27208545:T:C | - | 0.09247112848247 | 0.0290671834721602 | COAD | Female-baised eQTL |
| rs4665373 | chr2:27190123:G:A | - | 0.0921138934665276 | 0.0292540573294143 | COAD | Female-baised eQTL |
| rs4665374 | chr2:27190228:A:G | - | 0.0921138934665276 | 0.0292540573294143 | COAD | Female-baised eQTL |
| rs13399758 | chr2:27232858:T:C | - | -0.0889033577083525 | 0.0297652451650111 | COAD | Female-baised eQTL |
| rs7579087 | chr2:28104349:A:C | - | 0.123079693878122 | 0.0309941448321463 | COAD | Female-baised eQTL |
| rs1025778 | chr2:35259922:G:C | - | -0.0763055100025395 | 0.0338153211232715 | COAD | Female-baised eQTL |
| rs6543925 | chr2:35323999:T:C | - | 0.0722646584371904 | 0.0339514201572483 | COAD | Female-baised eQTL |
| rs17326929 | chr2:35102105:A:G | - | 0.0866256625253148 | 0.0358076046062206 | COAD | Female-baised eQTL |
| rs1275525 | chr2:27205834:A:C | - | 0.08559259161491 | 0.0363954181197277 | COAD | Female-baised eQTL |
| rs1275527 | chr2:27206009:C:G | - | 0.08559259161491 | 0.0363954181197277 | COAD | Female-baised eQTL |
| rs12622413 | chr2:28351406:C:T | - | 0.0819319727990456 | 0.0372973925140249 | COAD | Female-baised eQTL |
| rs2119085 | chr2:35220720:A:G | - | -0.0728440867033252 | 0.0406518748946962 | COAD | Female-baised eQTL |
| rs1275526 | chr2:27205947:C:G | - | 0.085784321129659 | 0.0432838627627517 | COAD | Female-baised eQTL |
| rs10207282 | chr2:35224758:C:T | - | -0.071702851394828 | 0.0442888243777676 | COAD | Female-baised eQTL |
| rs4670447 | chr2:35200073:G:A | - | -0.0731923134542953 | 0.045416953946151 | COAD | Female-baised eQTL |
| rs2580382 | chr2:27183687:A:G | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs1659682 | chr2:27187867:G:A | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs1659681 | chr2:27189415:A:G | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs1659700 | chr2:27191266:T:C | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs1659687 | chr2:27192189:A:G | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs4665375 | chr2:27193618:A:G | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs13012631 | chr2:27193975:G:A | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs1275502 | chr2:27195920:T:C | - | 0.0850043445900574 | 0.0460152834332676 | COAD | Female-baised eQTL |
| rs35348457 | chr2:35332233:G:C | - | 0.0700139006686103 | 0.0478782553952757 | COAD | Female-baised eQTL |
| rs10189794 | chr2:35280628:T:C | - | -0.0739276836809083 | 0.048531782796331 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1962069 | chr2:18072791:A:C | - | 0.218900739772611 | 0.00201588451685369 | PAAD | Male-baised eQTL |
| rs2580759 | chr2:27209632:T:G | - | 0.0678473697284846 | 0.0243373609359038 | HNSC | Male-baised eQTL |
| rs10166792 | chr2:20577389:A:C | - | -0.060549155686733 | 0.0257713886283103 | KIRC | Male-baised eQTL |
| rs4586632 | chr2:18923835:G:T | - | -0.0458738986969571 | 0.0287660032180121 | KIRC | Male-baised eQTL |
| rs7573016 | chr2:18461460:C:T | - | 0.0803270647125233 | 0.0290084997913513 | KIRC | Male-baised eQTL |
| rs7575337 | chr2:18921521:G:A | - | -0.0441006635207029 | 0.0447223701675852 | KIRC | Male-baised eQTL |
| rs2954818 | chr2:23373015:A:G | - | 0.0683572619750671 | 0.0456257145377619 | KIRC | Male-baised eQTL |
| rs4290655 | chr2:18921942:A:G | - | -0.0438150724255773 | 0.046932126742685 | KIRC | Male-baised eQTL |
| rs10195722 | chr2:20575854:C:T | - | -0.043401134139482 | 0.0478032101935713 | KIRC | Male-baised eQTL |
| rs4131345 | chr2:18924474:C:T | - | -0.0436871264381222 | 0.0487657850153229 | KIRC | Male-baised eQTL |
| rs11531372 | chr2:19584461:A:T | - | 0.0603646897558766 | 0.000996804335535289 | BLCA | Male-baised eQTL |
| rs6708210 | chr2:19586819:A:C | - | 0.0603646897558766 | 0.000996804335535289 | BLCA | Male-baised eQTL |
| rs7580499 | chr2:19581758:C:T | - | 0.0580272203900349 | 0.00264630677505251 | BLCA | Male-baised eQTL |
| rs1118208 | chr2:19613573:A:G | - | -0.0527592279744052 | 0.0116371282135822 | BLCA | Male-baised eQTL |
| rs2300881 | chr2:37310279:G:C | - | 0.0505738905175827 | 0.0121351449576685 | BLCA | Male-baised eQTL |
| rs4670688 | chr2:37313917:A:G | - | 0.0470582507443109 | 0.0130409126204411 | BLCA | Male-baised eQTL |
| rs6753075 | chr2:19613629:A:G | - | -0.0516881958795736 | 0.0146242888579488 | BLCA | Male-baised eQTL |
| rs6738502 | chr2:19613702:C:T | - | -0.0516881958795736 | 0.0146242888579488 | BLCA | Male-baised eQTL |
| rs11096606 | chr2:19615857:A:T | - | -0.0516881958795736 | 0.0146242888579488 | BLCA | Male-baised eQTL |
| rs10169966 | chr2:19616816:T:C | - | -0.0516881958795736 | 0.0146242888579488 | BLCA | Male-baised eQTL |
| rs6728951 | chr2:37186227:T:A | - | 0.0421682662494343 | 0.0155526591075949 | BLCA | Male-baised eQTL |
| rs4666534 | chr2:19668758:T:G | - | -0.0464981315587826 | 0.0167993859535915 | BLCA | Male-baised eQTL |
| rs12710720 | chr2:19612423:G:A | - | -0.0505722365889105 | 0.0171672103889893 | BLCA | Male-baised eQTL |
| rs11692172 | chr2:19612588:T:C | - | -0.0505722365889105 | 0.0171672103889893 | BLCA | Male-baised eQTL |
| rs12464978 | chr2:19622190:A:G | - | -0.0504244400521066 | 0.0173225627154462 | BLCA | Male-baised eQTL |
| rs4666519 | chr2:19626591:C:T | - | -0.0504244400521066 | 0.0173225627154462 | BLCA | Male-baised eQTL |
| rs2268987 | chr2:37306032:T:C | - | 0.0478358663178699 | 0.0176088172148028 | BLCA | Male-baised eQTL |
| rs6750313 | chr2:19586453:C:T | - | 0.0420839296320644 | 0.0183895671306252 | BLCA | Male-baised eQTL |
| rs4666521 | chr2:19634572:A:G | - | -0.0515531230095977 | 0.0193926311027896 | BLCA | Male-baised eQTL |
| rs11895771 | chr2:37185792:T:G | - | 0.041328941723067 | 0.0194498942241416 | BLCA | Male-baised eQTL |
| rs6531176 | chr2:19611761:C:T | - | -0.0498071398627637 | 0.0201762151964352 | BLCA | Male-baised eQTL |
| rs4670673 | chr2:37183820:T:G | - | 0.0413272556679003 | 0.0206616509338322 | BLCA | Male-baised eQTL |
| rs1453190 | chr2:19642667:G:A | - | -0.050320213217451 | 0.0215523751960932 | BLCA | Male-baised eQTL |
| rs6531187 | chr2:19643727:A:G | - | -0.050320213217451 | 0.0215523751960932 | BLCA | Male-baised eQTL |
| rs10201255 | chr2:19639209:G:C | - | -0.050695606755767 | 0.0229059519536221 | BLCA | Male-baised eQTL |
| rs1529392 | chr2:19640350:G:A | - | -0.050695606755767 | 0.0229059519536221 | BLCA | Male-baised eQTL |
| rs28463756 | chr2:37179000:C:T | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs10205589 | chr2:37179144:G:C | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs13401374 | chr2:37179723:A:G | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs13392521 | chr2:37180160:T:A | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs10865121 | chr2:37180694:G:C | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs6708343 | chr2:37181155:T:G | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs6750763 | chr2:37181405:C:T | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs6722371 | chr2:37181532:A:G | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs11895882 | chr2:37182005:A:G | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs11885265 | chr2:37182241:G:A | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs28627823 | chr2:37182365:T:C | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs59380055 | chr2:37182429:G:C | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs62134996 | chr2:37182607:G:A | - | 0.0404983924216279 | 0.0239078948626226 | BLCA | Male-baised eQTL |
| rs10432634 | chr2:37174092:C:A | - | 0.0398155838156799 | 0.0301295765357424 | BLCA | Male-baised eQTL |
| rs7604903 | chr2:28623695:A:G | - | 0.0359005923974334 | 0.0477315181524558 | BLCA | Male-baised eQTL |
| rs62161948 | chr2:34582842:A:G | - | 0.118846206325383 | 0.0364962414825218 | COAD | Male-baised eQTL |
| rs6711211 | chr2:33390285:T:C | - | -0.0514758320373482 | 0.0368492751611713 | COAD | Male-baised eQTL |
| rs1869304 | chr2:19723186:G:A | - | -0.0481241867656639 | 0.0433733504645988 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg04845466 | chr2:27442212 | promoter | -0.238673695214071 | 6.96791409135297e-06 | -0.5273555552472226 | 2.4183356901384844e-08 | PAAD |
| cg26034919 | chr2:27442844 | gene,exon,CDS,promoter | -0.233399608916327 | 1.7440751926911e-13 | -0.5319864538484468 | 4.408922794075453e-16 | KIRP |
| cg18428193 | chr2:27442150 | promoter | -0.425508843470553 | 8.25904804091332e-06 | -0.35961106312752616 | 1.5796242443803104e-07 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_324175 | chr2:27443948:27444061 | 3UTR-3CDS | rs4665409 | chr2:28302349:G:A | Distant downstream | -0.0734368202973718 | 0.0215172623883576 | COAD | Female-baised sQTL |
| exon_skip_324175 | chr2:27443948:27444061 | 3UTR-3CDS | rs60183653 | chr2:28304692:C:T | Distant downstream | -0.0734368202973718 | 0.0215172623883576 | COAD | Female-baised sQTL |
| exon_skip_324175 | chr2:27443948:27444061 | 3UTR-3CDS | rs13031756 | chr2:28309036:A:G | Distant downstream | -0.0684844566544052 | 0.0345286358813075 | COAD | Female-baised sQTL |
| exon_skip_324175 | chr2:27443948:27444061 | 3UTR-3CDS | rs4665408 | chr2:28298190:C:T | Distant downstream | -0.0685675375204962 | 0.0373777472227032 | COAD | Female-baised sQTL |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of KRTCAP3 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |